EVOTEC BioSystems - Kaufen mit Kursziel 196 €
WKN: 566480 EVOTEC BIOSYSTEMS AG O.N. Sal.Oppenheim 17.07.2000
New direction in pre-clinical drug discovery
* Technology collaboration agreements with leading pharmaceutical companies in the world form the basis of future orientation: positioning as service-provider for the pharmaceutical industry as well as own projects for identifying new active substances
* Leading proprietary platform technologies for ultra-high-throughput screening enable a faster, more precise and more efficient search for new active substances
* Half-year sales are expected to rise strongly and the operating loss should come out at DM16m
* Excellent future growth prospects, price target € 196.
gis/tf - © wallstreet-online GmbH
WKN: 566480 EVOTEC BIOSYSTEMS AG O.N. Sal.Oppenheim 17.07.2000
New direction in pre-clinical drug discovery
* Technology collaboration agreements with leading pharmaceutical companies in the world form the basis of future orientation: positioning as service-provider for the pharmaceutical industry as well as own projects for identifying new active substances
* Leading proprietary platform technologies for ultra-high-throughput screening enable a faster, more precise and more efficient search for new active substances
* Half-year sales are expected to rise strongly and the operating loss should come out at DM16m
* Excellent future growth prospects, price target € 196.
gis/tf - © wallstreet-online GmbH
